DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Thomas MB, Chadha R, Glover K , et al.
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
Cancer 2007;
110 (5) 1059-1067
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.